Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedThe study page adds an Amyloidosis topic and a Genetic and Rare Diseases Information Center resource, along with a new citation for a 2026 JAMA Cardiol article. A previously listed JAMA Cardiol article reference was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check70 days agoChange DetectedShow glossary option added; Brno-střed, Czechia added as a location. QC-related text updated (Last Update Submitted that Met QC Criteria) and the revision shows v3.4.0, with capitalization changes for No FEAR Act Data.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded a citation for a plain-language review of ATTRibute-CM by Gillmore et al. (Future Cardiol. 2025) to Publications. Removed the older online-ahead-of-print citation and updated the entry to Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.